Invention Grant
- Patent Title: Nucleic acid encoding anti-IL13 human antibodies
-
Application No.: US14629587Application Date: 2015-02-24
-
Publication No.: US09650438B2Publication Date: 2017-05-16
- Inventor: Emma Michelle Campbell , Sofia Parveen , Joe Buechler , Gunars Valkirs
- Applicant: Emma Michelle Campbell , Sofia Parveen , Joe Buechler , Gunars Valkirs
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Priority: GB0521509.0 20051021; GB0616666.4 20060822
- Main IPC: C12N15/64
- IPC: C12N15/64 ; C07K16/24 ; C12P21/02 ; A61K38/01 ; C12N15/81 ; A61K38/12 ; A61K39/00
Abstract:
The present invention relates to human anti-IL-13 binding molecules, particularly antibodies, and to methods for using anti-IL-13 antibody molecules in diagnosis or treatment of IL-13 related disorders, such as asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma.
Public/Granted literature
- US20170101467A9 Nucleic Acid Encoding Anti-IL13 Human Antibodies Public/Granted day:2017-04-13
Information query
IPC分类:
